The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Molecular Tumor Board Solutions Market From 2026 To 2030?
The molecular tumor board solutions market size has experienced swift expansion in recent years. It is anticipated to grow from $1.53 billion in 2025 to $1.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.7%. This historical growth can be primarily attributed to the expansion of precision oncology programs, the increasing availability of genomic sequencing data, the development of multidisciplinary cancer care teams, the rising adoption of clinical decision support software, and improved data sharing across oncology centers.
The molecular tumor board solutions market size is anticipated to undergo substantial growth in the upcoming years. It is projected to expand to $2.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.4%. The expansion within the forecast period is driven by increasing investments in personalized cancer treatment, a rising demand for molecularly guided therapies, the broadening of cloud deployment in healthcare, a growing integration with clinical trial matching platforms, and the increasing adoption of AI-driven oncology analytics. Prominent trends for this period encompass the increasing use of AI-assisted variant interpretation, the growing integration of multimodal genomic data, the expansion of cloud-based tumor board platforms, a rising adoption of collaborative decision support tools, and an enhanced focus on personalized oncology workflows.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28274&type=smp
Which Drivers Are Supporting The Molecular Tumor Board Solutions Market Growth?
The increasing incidence of cancer is anticipated to boost the expansion of the molecular tumor board solutions market in the future. Cancer is defined as a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells within the body. The growing occurrence of cancer stems from lifestyle factors, including inadequate nutrition, tobacco use, sedentary habits, and excessive alcohol intake. Molecular tumor board solutions assist in cancer management by offering expert, cross-disciplinary analysis of patients’ genomic and clinical information, thereby facilitating tailored treatment approaches. These solutions improve clinical decision-making through the incorporation of molecular profiling and insights generated by AI, leading to better patient outcomes and greater treatment accuracy. For example, the World Health Organization, a global public health agency based in Switzerland, reported in February 2024 that more than 35 million new cancer cases are projected by 2050, representing a 77% rise from the approximately 20 million cases estimated in 2022. Consequently, the growing incidence of cancer is propelling the development of the molecular tumor board solutions market.
How Is The Molecular Tumor Board Solutions Market Segmented Across Different Segment Categories?
The molecular tumor board solutions market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Clinical Decision Support, Genomic Data Interpretation, Patient Management, Other Applications
4) By End-User: Hospitals, Cancer Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Clinical Decision Support, Data Analytics, Reporting And Visualization, Integration Platforms
2) By Services: Consulting, Implementation, Training And Support, Maintenance And Upgrades
Which Trends Are Expected To Impact The Molecular Tumor Board Solutions Market?
Leading companies in the molecular tumor board solutions market are prioritizing the development of innovative offerings, such as molecular profiling tests, to improve the accuracy and effectiveness of cancer diagnostics and subsequent treatment planning. Molecular profiling tests are diagnostic tools that analyze a tumor’s genetic and molecular characteristics to inform personalized cancer treatment decisions. For instance, in April 2025, Guardant Health Inc., a US-based biotechnology and precision oncology company, introduced Guardant360 Tissue, a pioneering molecular profiling test for tumor tissue that integrates comprehensive multiomic analysis, including DNA, RNA, AI-powered PD-L1, and genome-wide methylation data. This advanced test, powered by the Guardant Infinity smart liquid biopsy platform, provides a more complete and multidimensional perspective on cancer, enabling higher resolution tumor classification and subtyping. Guardant360 Tissue delivers results in under two weeks, is covered by Medicare for eligible patients, and aims to enhance precision oncology by offering deeper insights to guide treatment decisions, including for therapies such as poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapies.
Which Organizations Play A Role In The Molecular Tumor Board Solutions Market Landscape?
Major companies operating in the molecular tumor board solutions market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Illumina Inc., Novogene Co. Ltd., QIAGEN N.V., Myriad Genetics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Mayo Clinic Laboratories, Sectra AB, GenomOncology LLC, MedGenome Labs Ltd., Burning Rock Biotech Limited, NantHealth Inc., SOPHiA GENETICS SA, Variantyx Inc., Baylor Genetics, Molecular Health GmbH, PierianDx Inc., Oncompass Medicine, CureMatch Inc.
Get The Full Molecular Tumor Board Solutions Market Report:
Which Region Dominates The Molecular Tumor Board Solutions Market By Market Share?
North America was the largest region in the molecular tumor board solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular tumor board solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Molecular Tumor Board Solutions Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Molecular Tumor Board Solutions Market 2026, By The Business Research Company
Structural Biology And Molecular Modeling Techniques Market Report 2026
Molecular Spectroscopy Market Report
https://www.thebusinessresearchcompany.com/report/molecular-spectroscopy-global-market-report
Small Molecule Api Market Report
https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model